These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 16988507

  • 1. Low-dose oxaliplatin enhances the antitumor efficacy of paclitaxel in human gastric cancer cell lines.
    Gu J, Yamamoto H, Lu X, Ngan CY, Tsujino T, Konishi K, Takemasa I, Ikeda M, Nagata H, Hashimoto S, Matsuzaki T, Sekimoto M, Takagi A, Monden M.
    Digestion; 2006; 74(1):19-27. PubMed ID: 16988507
    [Abstract] [Full Text] [Related]

  • 2. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
    Fujie Y, Yamamoto H, Ngan CY, Takagi A, Hayashi T, Suzuki R, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M.
    Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
    [Abstract] [Full Text] [Related]

  • 3. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
    Koutcher JA, Motwani M, Zakian KL, Li XK, Matei C, Dyke JP, Ballon D, Yoo HH, Schwartz GK.
    Clin Cancer Res; 2000 Apr; 6(4):1498-507. PubMed ID: 10778982
    [Abstract] [Full Text] [Related]

  • 4. In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines.
    Tanaka R, Ariyama H, Qin B, Takii Y, Baba E, Mitsugi K, Harada M, Nakano S.
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):595-601. PubMed ID: 15731917
    [Abstract] [Full Text] [Related]

  • 5. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.
    Shi M, Lou B, Ji J, Shi H, Zhou C, Yu Y, Liu B, Zhu Z, Zhang J.
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327
    [Abstract] [Full Text] [Related]

  • 6. Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxel.
    Khan Z, Khan N, Varma AK, Tiwari RP, Mouhamad S, Prasad GB, Bisen P.
    Curr Cancer Drug Targets; 2010 Nov; 10(7):660-9. PubMed ID: 20578991
    [Abstract] [Full Text] [Related]

  • 7. In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.
    Qin B, Tanaka R, Shibata Y, Arita S, Ariyama H, Kusaba H, Baba E, Harada M, Nakano S.
    Anticancer Drugs; 2006 Apr; 17(4):445-53. PubMed ID: 16550003
    [Abstract] [Full Text] [Related]

  • 8. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
    Lin J, Hsiao PW, Chiu TH, Chao JI.
    Biochem Pharmacol; 2005 Sep 01; 70(5):658-67. PubMed ID: 16004971
    [Abstract] [Full Text] [Related]

  • 9. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
    Tanaka R, Takii Y, Shibata Y, Ariyama H, Qin B, Baba E, Kusaba H, Mitsugi K, Harada M, Nakano S.
    Cancer Chemother Pharmacol; 2005 Sep 01; 56(3):279-85. PubMed ID: 15875187
    [Abstract] [Full Text] [Related]

  • 10. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R, Tanabe K, Inoue H, Toge T.
    Int J Oncol; 2002 Mar 01; 20(3):549-55. PubMed ID: 11836567
    [Abstract] [Full Text] [Related]

  • 11. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL, Watson JM, Gehrig PA, Fowler WC, Haskill JS.
    Cancer Res; 1999 May 15; 59(10):2425-32. PubMed ID: 10344753
    [Abstract] [Full Text] [Related]

  • 12. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 15; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 13. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
    Li J, Liu P, Mao H, Wanga A, Zhang X.
    Oncol Rep; 2009 Jun 15; 21(6):1605-10. PubMed ID: 19424643
    [Abstract] [Full Text] [Related]

  • 14. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells.
    Pratt MA, Niu MY, Renart LI.
    Apoptosis; 2006 Apr 15; 11(4):589-605. PubMed ID: 16528475
    [Abstract] [Full Text] [Related]

  • 15. The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines.
    Xu JM, Azzariti A, Colucci G, Paradiso A.
    Cancer Chemother Pharmacol; 2003 Dec 15; 52(6):442-8. PubMed ID: 13680161
    [Abstract] [Full Text] [Related]

  • 16. Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer.
    Sohma I, Fujiwara Y, Sugita Y, Yoshioka A, Shirakawa M, Moon JH, Takiguchi S, Miyata H, Yamasaki M, Mori M, Doki Y.
    Cancer Genomics Proteomics; 2011 Dec 15; 8(1):39-47. PubMed ID: 21289336
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of melphalan, oxaliplatin, and paclitaxel in colon, liver, and gastric cancer cell lines in a short-term exposure model of chemosaturation therapy by percutaneous hepatic perfusion.
    Uzgare RP, Sheets TP, Johnston DS.
    Anticancer Res; 2013 May 15; 33(5):1989-2000. PubMed ID: 23645748
    [Abstract] [Full Text] [Related]

  • 18. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.
    Motwani M, Delohery TM, Schwartz GK.
    Clin Cancer Res; 1999 Jul 15; 5(7):1876-83. PubMed ID: 10430095
    [Abstract] [Full Text] [Related]

  • 19. Synergistic interaction between oxaliplatin and SN-38 in human gastric cancer cell lines in vitro.
    Tanaka R, Ariyama H, Qin B, Shibata Y, Takii Y, Kusaba H, Baba E, Mitsugi K, Harada M, Nakano S.
    Oncol Rep; 2005 Sep 15; 14(3):683-8. PubMed ID: 16077975
    [Abstract] [Full Text] [Related]

  • 20. Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cells.
    Ngan CY, Yamamoto H, Takagi A, Fujie Y, Takemasa I, Ikeda M, Takahashi-Yanaga F, Sasaguri T, Sekimoto M, Matsuura N, Monden M.
    Cancer Sci; 2008 Jan 15; 99(1):129-39. PubMed ID: 17949450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.